- Home
- ZOOZ vs AEON Comparison
ZOOZ vs AEON Comparison
Compare ZOOZ & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOOZ
- AEON
- Stock Information
- Founded
- ZOOZ 2013
- AEON N/A
- Country
- ZOOZ Israel
- AEON United States
- Employees
- ZOOZ N/A
- AEON N/A
- Industry
- ZOOZ
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- ZOOZ
- AEON Health Care
- Exchange
- ZOOZ NYSE
- AEON Nasdaq
- Market Cap
- ZOOZ 8.8M
- AEON 8.0M
- IPO Year
- ZOOZ N/A
- AEON N/A
- Fundamental
- Price
- ZOOZ $1.09
- AEON $0.81
- Analyst Decision
- ZOOZ Strong Buy
- AEON Strong Buy
- Analyst Count
- ZOOZ 2
- AEON 1
- Target Price
- ZOOZ $5.00
- AEON $360.00
- AVG Volume (30 Days)
- ZOOZ 69.8K
- AEON 213.7K
- Earning Date
- ZOOZ 08-11-2025
- AEON 08-11-2025
- Dividend Yield
- ZOOZ N/A
- AEON N/A
- EPS Growth
- ZOOZ N/A
- AEON N/A
- EPS
- ZOOZ N/A
- AEON 117.22
- Revenue
- ZOOZ $1,041,000.00
- AEON N/A
- Revenue This Year
- ZOOZ $32.28
- AEON N/A
- Revenue Next Year
- ZOOZ $192.59
- AEON N/A
- P/E Ratio
- ZOOZ N/A
- AEON $0.01
- Revenue Growth
- ZOOZ 36.26
- AEON N/A
- 52 Week Low
- ZOOZ $0.73
- AEON $0.38
- 52 Week High
- ZOOZ $3.07
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- ZOOZ N/A
- AEON 56.89
- Support Level
- ZOOZ N/A
- AEON $0.80
- Resistance Level
- ZOOZ N/A
- AEON $0.87
- Average True Range (ATR)
- ZOOZ 0.00
- AEON 0.06
- MACD
- ZOOZ 0.00
- AEON -0.00
- Stochastic Oscillator
- ZOOZ 0.00
- AEON 61.23
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency and greater flexibility.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.